201 results
Page 5 of 11
424B5
3b7gd95cti885xcd8
9 May 13
Prospectus supplement for primary offering
12:00am
424B5
nv8l4ir c7rr
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
trlb7qz2sao
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
tpn6hc1im0e7n6navf
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
vb3gc9sw
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
EX-99.1
pa1e042w
3 Aug 11
Results of Operations and Financial Condition
12:00am
8-K
qxd6vsjoywmrvwl0ypx
18 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
1bk ko7fur1u
18 Jul 11
Departure of Directors or Certain Officers
12:00am